SFX by Ex Libris Inc.

Title:	Stereoselective disposition of carvedilol in man after intravenous and oral administration of the racemic compound
Source:	European Journal of Clinical Pharmacology [0031-6970] Neugebauer, G yr:1990

Basic

Full text

Full text available via SpringerLINK Contemporary 1997-Present

Year:

Volume:

Issue:

Start Page:

Full text available via SpringerLink Historical Archives Biomedical and Life Sciences

Year:

Volume:

Issue:

Start Page:

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Davies, Neal M. "Clinical pharmacokinetics and pharmacodynamics of celecoxib: a selective cyclooxygenase-2 inhibitor." Clinical pharmacokinetics 38.3 (2000): 225-42.
description	2.	FUJIMAKI, M. "Stereoselective metabolism of carvedilol in the rat. Use of enantiomerically radiolabeled pseudoracemates." Drug metabolism and disposition 19.4 (1991): 749-53.
description	3.	Stoschitzky K, K. "Different stereoselective effects of (R)- and (S)-propafenone: clinical pharmacologic, electrophysiologic, and radioligand binding studies." Clinical pharmacology and therapeutics 47.6 (1990): 740-746.
description	4.	Norling, Lucy V. "The role of omega-3 derived resolvins in arthritis." Current opinion in pharmacology 13.3 (2013): 476-481.
description	5.	James, Michael J J. "Dietary omega-3 fats for treatment of inflammatory joint disease: efficacy and utility." Rheumatic diseases clinics of North America 34.2 (2008): 469-79.
description	6.	Gelmann, A. "Effect of CYP2C9 genotype on the pharmacokinetics of celecoxib." Clinical pharmacology & therapeutics 69.2 (2001).
description	7.	Davies, Neal M. "Pharmacokinetics of rofecoxib - A specific cyclo-oxygenase-2 inhibitor." Clinical pharmacokinetics 42.6 (2003): 545-556.
description	8.	Loeve, S. "Metaphors in Nanomedicine: The Case of Targeted Drug Delivery." NanoEthics 8.1 (2014): 1-17.
description	9.	Bertera, Facundo M. "Enantioselective pharmacokinetic and pharmacodynamic properties of carvedilol in spontaneously hypertensive rats: focus on blood pressure variability." Naunyn-Schmiedeberg's archives of pharmacology 385.3 (2012): 325-335.
description	10.	Adams, S. S. S. "Pharmacological differences between the optical isomers of ibuprofen : evidence for metabolic inversion of the (-)-isomer." Journal of Pharmacy and Pharmacology 28.3 (1976): 256-257.
description	11.	Anderson, Gail D D. "Using pharmacokinetics to predict the effects of pregnancy and maternal-infant transfer of drugs during lactation." Expert Opinion on Drug Metabolism and Toxicology 2.6 (2006): 947-960.
description	12.	Galarraga, B. "Cod liver oil (n-3 fatty acids) as an non-steroidal anti-inflammatory drug sparing agent in rheumatoid arthritis." Rheumatology 47.5 (2008): 665-9.
description	13.	Cleland, L. "The Role of Fish Oils in the Treatment of Rheumatoid Arthritis." Drugs 63.9 (2003): 845-853.
description	14.	Berbert, A. "Supplementation of fish oil and olive oil in patients with rheumatoid arthritis." Nutrition 21.2 (2005): 131-6.
description	15.	Lee, Young-Ho H. "Omega-3 Polyunsaturated Fatty Acids and Rheumatoid Arthritis Treatment: A Meta-analysis." Archives of medical research 43.5 (2012): 356-362.
description	16.	Katz, J. "A meta-analysis of the analgesic effects of omega-3 polyunsaturated fatty acid supplementation for inflammatory joint pain." Pain 129.1-2 (2007): 210-23.
description	17.	Malhotra, S. "COX-2 inhibitors: a CLASS act or Just VIGORously promoted." MedGenMed 6.1 (2004): 6-6.
description	18.	Rahman, Md Mizanur M. "Docosahexaenoic acid is more potent inhibitor of osteoclast differentiation in RAW 264.7 cells than eicosapentaenoic acid." Journal of cellular physiology 214.1 (2007): 201-9.
description	19.	Lim, Giselle P. "A Diet Enriched with the Omega-3 Fatty Acid Docosahexaenoic Acid Reduces Amyloid Burden in an Aged Alzheimer Mouse Model." The journal of neuroscience 25.12 (2005): 3032-3040.
description	20.	Burgess, John R R. "Omega-3 fatty acid status in attention-deficit/hyperactivity disorder." Prostaglandins, leukotrienes, and essential fatty acids 75.4-5 (2006): 299-308.